Bruker Gross Margin 2010-2023 | BRKR
Current and historical gross margin for Bruker (BRKR) over the last 10 years. The current gross profit margin for Bruker as of December 31, 2023 is %.
| Bruker Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2023-12-31 |
$2.96B |
$1.51B |
51.08% |
| 2023-09-30 |
$2.82B |
$1.45B |
51.45% |
| 2023-06-30 |
$2.71B |
$1.40B |
51.66% |
| 2023-03-31 |
$2.62B |
$1.36B |
51.87% |
| 2022-12-31 |
$2.53B |
$1.31B |
51.58% |
| 2022-09-30 |
$2.51B |
$1.28B |
51.14% |
| 2022-06-30 |
$2.48B |
$1.26B |
50.71% |
| 2022-03-31 |
$2.46B |
$1.24B |
50.37% |
| 2021-12-31 |
$2.42B |
$1.21B |
50.08% |
| 2021-09-30 |
$2.36B |
$1.18B |
50.02% |
| 2021-06-30 |
$2.27B |
$1.12B |
49.49% |
| 2021-03-31 |
$2.12B |
$1.03B |
48.42% |
| 2020-12-31 |
$1.99B |
$0.94B |
47.23% |
| 2020-09-30 |
$1.96B |
$0.92B |
47.04% |
| 2020-06-30 |
$1.97B |
$0.93B |
47.11% |
| 2020-03-31 |
$2.04B |
$0.97B |
47.76% |
| 2019-12-31 |
$2.07B |
$1.00B |
48.02% |
| 2019-09-30 |
$2.03B |
$0.97B |
47.98% |
| 2019-06-30 |
$1.97B |
$0.94B |
47.72% |
| 2019-03-31 |
$1.93B |
$0.92B |
47.56% |
| 2018-12-31 |
$1.90B |
$0.90B |
47.44% |
| 2018-09-30 |
$1.87B |
$0.88B |
47.12% |
| 2018-06-30 |
$1.84B |
$0.86B |
46.61% |
| 2018-03-31 |
$1.81B |
$0.84B |
46.25% |
| 2017-12-31 |
$1.77B |
$0.82B |
46.18% |
| 2017-09-30 |
$1.71B |
$0.78B |
45.90% |
| 2017-06-30 |
$1.66B |
$0.77B |
46.21% |
| 2017-03-31 |
$1.62B |
$0.75B |
46.51% |
| 2016-12-31 |
$1.61B |
$0.75B |
46.24% |
| 2016-09-30 |
$1.62B |
$0.73B |
45.34% |
| 2016-06-30 |
$1.62B |
$0.72B |
44.23% |
| 2016-03-31 |
$1.65B |
$0.72B |
43.53% |
| 2015-12-31 |
$1.62B |
$0.71B |
43.66% |
| 2015-09-30 |
$1.65B |
$0.71B |
43.11% |
| 2015-06-30 |
$1.68B |
$0.71B |
42.43% |
| 2015-03-31 |
$1.74B |
$0.74B |
42.78% |
| 2014-12-31 |
$1.81B |
$0.76B |
42.23% |
| 2014-09-30 |
$1.85B |
$0.78B |
42.31% |
| 2014-06-30 |
$1.87B |
$0.81B |
43.27% |
| 2014-03-31 |
$1.87B |
$0.81B |
43.37% |
| 2013-12-31 |
$1.84B |
$0.81B |
43.83% |
| 2013-09-30 |
$1.80B |
$0.81B |
44.96% |
| 2013-06-30 |
$1.81B |
$0.83B |
45.67% |
| 2013-03-31 |
$1.78B |
$0.81B |
45.76% |
| 2012-12-31 |
$1.79B |
$0.83B |
46.26% |
| 2012-09-30 |
$1.75B |
$0.81B |
46.06% |
| 2012-06-30 |
$1.72B |
$0.79B |
45.64% |
| 2012-03-31 |
$1.70B |
$0.78B |
45.94% |
| 2011-12-31 |
$1.65B |
$0.75B |
45.61% |
| 2011-09-30 |
$1.59B |
$0.73B |
45.92% |
| 2011-06-30 |
$1.48B |
$0.69B |
46.43% |
| 2011-03-31 |
$1.38B |
$0.64B |
46.24% |
| 2010-12-31 |
$1.31B |
$0.60B |
46.28% |
| 2010-09-30 |
$1.26B |
$0.59B |
47.17% |
| 2010-06-30 |
$1.21B |
$0.56B |
46.61% |
| 2010-03-31 |
$1.16B |
$0.54B |
46.47% |
| 2009-12-31 |
$1.12B |
$0.52B |
46.37% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$11.768B |
$2.965B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
